Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
42nd Annual Meeting of the American Society of Clinical Oncology
Targeted Therapy: A Treatment Advance in Renal Cell Carcinoma
Atlanta, Georgia / June 2-6, 2006
Atlanta - For the past two decades, the treatment of advanced renal cell carcinoma has been limited to two cytokines: interferon alpha (IFNa) and interleukin-2 (IL-2). IFNa is associated with an 11% response rate, while IL-2 has a response...
42nd Annual Meeting of the American Society of Clinical Oncology
Chemopreventive Strategies in Prostate Cancer: Resolving an Enigma
Atlanta, Georgia / June 2-5, 2006
Atlanta - The Prostate Cancer Prevention Trial showed that treatment with the 5-alpha reductase inhibitor finasteride reduced the period prevalence of prostate cancer by 25% over its seven-year span compared with placebo. However, questions...
101st Annual Meeting of the American Urological Association (AUA)
Novel Findings and Therapy Strategies in Prostate Disease
Atlanta, Georgia / May 20-25, 2006
Atlanta - With the aging of western populations, the spectre of prostate disease emerges as a major health issue, with an estimated 12 million men in the US who have enlarged prostates and another 1.6 million who have prostate cancer. The...
101st Annual Meeting of the American Urological Association
The Evolution of 5-alpha Reductase Inhibition in Benign Prostatic Hyperplasia and Prostate Cancer Prevention
Atlanta, Georgia / May 20-25, 2006
Atlanta - Prostate disease poses a major health issue whose scope and consequences will continue to grow as Western populations age. According to the National Cancer Institute of Canada, in 2006, almost 21,000 Canadian men will be diagnosed...
21st Annual Congress of the European Association of Urology
Finding the Key to Dihydrotestosterone Control in Prostate Cancer Prevention
Paris, France / April 5-8, 2006
Paris - Dihydrotestosterone (DHT) plays a central role in both normal and abnormal prostate growth. Manipulation of DHT levels via inhibition of the enzyme 5 alpha-reductase (5AR) has proven to be an effective means of treating benign...
21st Annual Congress of the European Association of Urology
Multikinase Inhibition in the Management of Renal Cell Carcinoma: The Role of Urologists
Paris, France / April 5-8, 2006
Paris - Greater understanding of molecular biology and the impact of genetic mutations on intracellular pathways in kidney cancer cells has led to the identification of several receptors and signalling molecules as targets for the treatment...
21st Annual Congress of the European Association of Urology
Overactive Bladder: Examining New Therapeutic Avenues
Paris, France / April 5-8, 2006
Paris - According to the World Health Organization, bladder control problems affect more than 200 million people worldwide, with overactive bladder (OAB) being one of the most common and troublesome causes. OAB symptoms can be bothersome,...
21st Annual Congress of the European Association of Urology
A Relevant Therapeutic Target for Patients with Benign Prostatic Hyperplasia
Paris, France / April 5-8, 2006
Paris - Despite a sustained increase in the use of medical therapy for symptomatic benign prostatic hyperplasia (BPH) in recent years, watchful waiting has remained the North American treatment of choice for BPH below the threshold for...
2006 Annual Society for Urodynamics and Female Urology Meeting
Update on Neuromodulation and New Options for Stress Urinary Incontinence
Port Lucaya, Bahamas / February 22-25, 2006
Port Lucaya - Adjustable Continence Therapy, or ACTâ„¢ (ProACTâ„¢ for men), is a new minimally invasive, conveniently adjustable device that successfully controls stress urinary incontinence. The device consists of two small balloons implanted...